The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...
Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the ...
A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.
Glp-1 Analogues Market OverviewThe Glp analogues market size is expected to be worth USD 606.3 billion by 2034.The target market was valued at USD 45.3 billion in 2024.The market is projected to grow ...
Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...
If your constipation lasts for more than 3 days, speak with your doctor about options to help. You might need to add a stool ...
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...
GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...
The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...
In December 2024, the Centers for Medicare & Medicaid Services (CMS) formally approved a new quality measure developed by the ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...